Association between depression and survival in Chinese amyotrophic lateral sclerosis patients

详细信息    查看全文

• 作者：Qianqian Wei ; Zhenzhen Zheng ; Xiaoyan Guo ; Ruwei Ou ; Xueping Chen…
• 关键词：Amyotrophic lateral sclerosis ; Depression ; ALS Functional Rating Scale ; Revised (ALSFRS ; R) ; Survival ; Progression
• 刊名：Neurological Sciences
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：37
• 期：4
• 页码：557-563
• 全文大小：419 KB
• 参考文献：1.Strong MJ (2001) Progress in clinical neurosciences: the evidence for ALS as a multisystems disorder of limited phenotypic expression. Can J Neurol Sci 28(4):283–298CrossRef PubMed
  2.Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344(22):1688–1700CrossRef PubMed
  3.Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 347(9013):1425–1431CrossRef PubMed
  4.Phukan J, Pender NP, Hardiman O (2007) Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 6(11):994–1003CrossRef PubMed
  5.Atassi N, Cook A, Pineda CM, Yerramilli-Rao P, Pulley D, Cudkowicz M (2011) Depression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 12(2):109–112CrossRef PubMed PubMedCentral
  6.Oh H, Sin MK, Schepp KG, Choi-Kwon S (2012) Depressive symptoms and functional impairment among amyotrophic lateral sclerosis patients in South Korea. Rehabil Nurs 37(3):136–144CrossRef PubMed
  7.Olsson Ozanne AG, Strang S, Persson LI (2011) Quality of life, anxiety and depression in ALS patients and their next of kin. J Clin Nurs 20(1–2):283–291CrossRef PubMed
  8.Rabkin JG, Albert SM, Del Bene ML, O’Sullivan I, Tider T, Rowland LP, Mitsumoto H (2005) Prevalence of depressive disorders and change over time in late-stage ALS. Neurology 65(1):62–67CrossRef PubMed PubMedCentral
  9.Pagnini F, Manzoni GM, Tagliaferri A, Gibbons CJ (2015) Depression and disease progression in amyotrophic lateral sclerosis: a comprehensive meta-regression analysis. J Health Psychol 20(8):1107–1128CrossRef PubMed
  10.McElhiney MC, Rabkin JG, Gordon PH, Goetz R, Mitsumoto H (2009) Prevalence of fatigue and depression in ALS patients and change over time. J Neurol Neurosurg Psychiatry 80(10):1146–1149CrossRef PubMed
  11.Bocker FM, Seibold I, Neundorfer B (1990) Disability in everyday tasks and subjective status of patients with advanced amyotrophic lateral sclerosis. Fortschr Neurol Psychiatr 58(6):224–236CrossRef PubMed
  12.Ferentinos P, Paparrigopoulos T, Rentzos M, Zouvelou V, Alexakis T, Evdokimidis I (2011) Prevalence of major depression in ALS: comparison of a semi-structured interview and four self-report measures. Amyotroph Lateral Scler 12(4):297–302CrossRef PubMed
  13.Trail M, Nelson ND, Van JN, Appel SH, Lai EC (2003) A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. J Neurol Sci 209(1–2):79–85CrossRef PubMed
  14.Hillemacher T, Grassel E, Tigges S, Bleich S, Neundorfer B, Kornhuber J, Hecht MJ (2004) Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 5(4):245–249CrossRef PubMed
  15.Körner S, Kollewe K, Abdulla S, Zapf A, Dengler R, Petri S (2015) Interaction of physical function, quality of life and depression in amyotrophic lateral sclerosis: characterization of a large patient cohort. BMC Neurol 15:84CrossRef PubMed PubMedCentral
  16.Grehl T, Rupp M, Budde P, Tegenthoff M, Fangerau H (2011) Depression and QOL in patients with ALS: how do self-ratings and ratings by relatives differ? Qual Life Res 20(4):569–574CrossRef PubMed
  17.Lule D, Hacker S, Ludolph A, Birbaumer N, Kubler A (2008) Depression and quality of life in patients with amyotrophic lateral sclerosis. Dtsch Arztebl Int 105(23):397–403PubMed PubMedCentral
  18.Rabkin JG, Wagner GJ, Del Bene M (2000) Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med 62(2):271–279CrossRef PubMed
  19.McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA (1994) Survival in amyotrophic lateral sclerosis. The role of psychological factors, Arch Neurol 51(1):17–23CrossRef PubMed
  20.Zimmerman M, McGlinchey JB, Young D, Chelminski I (2006) Diagnosing major depressive disorder I: a psychometric evaluation of the DSM-IV symptom criteria. J Nerv Ment Dis 194(3):158–163CrossRef PubMed
  21.Brooks BR, Miller RG, Swash M, Munsat TL, World Federation Neurology Res G (2000) El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Scler Other Motor Neuron Dis 1(5):293–299CrossRef
  22.Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169(1–2):13–21CrossRef PubMed
  23.Group GLAS (2003) A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis. Neurology 61(11):1503–1507CrossRef
  24.Moberg PJ, Lazarus LW, Mesholam RI, Bilker W, Chuy IL, Neyman I, Markvart V (2001) Comparison of the standard and structured interview guide for the Hamilton Depression Rating Scale in depressed geriatric inpatients. Am J Geriatr Psychiatry 9(1):35–40CrossRef PubMed
  25.Beck AT, Rial WY, Rickels K (1974) Short form of depression inventory: cross-validation. Psychol Rep 34(3):1184–1186CrossRef PubMed
  26.Swinscow TD (1976) Statistics at square one: XVIII-Correlation. Br Med J 2(6037):680–681CrossRef PubMed PubMedCentral
  27.Ganzini L, Johnston WS, Hoffman WF (1999) Correlates of suffering in amyotrophic lateral sclerosis. Neurology 52(7):1434–1440CrossRef PubMed
  28.Kurt A, Nijboer F, Matuz T, Kubler A (2007) Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management. CNS Drugs 21(4):279–291CrossRef PubMed
  29.Narrow WE, Rae DS, Robins LN, Regier DA (2002) Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys’ estimates. Arch Gen Psychiatry 59(2):115–123CrossRef PubMed
  30.Feinstein A, Feinstein K (2001) Depression associated with multiple sclerosis’. Looking beyond diagnosis to symptom expression. J Affect Disord 66(2–3):193–198CrossRef PubMed
  31.Galeazzi GM, Ferrari S, Giaroli G, Mackinnon A, Merelli E, Motti L, Rigatelli M (2005) Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy. Neurol Sci 26(4):255–262CrossRef PubMed
  32.Frick E, Tyroller M, Panzer M (2007) Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: a cross-sectional study in a community hospital outpatient centre. Eur J Cancer Care (Engl) 16(2):130–136CrossRef
  33.Averill AJ, Kasarskis EJ, Segerstrom SC (2007) Psychological health in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 8(4):243–254CrossRef PubMed
  34.McLeod JE, Clarke DM (2007) A review of psychosocial aspects of motor neurone disease. J Neurol Sci 258(1–2):4–10CrossRef PubMed
  35.Caga J, Ramsey E, Hogden A, Mioshi E, Kiernan MC (2015) A longer diagnostic interval is a risk for depression in amyotrophic lateral sclerosis. Palliat Support Care 13(4):1019–1024CrossRef PubMed
  36.Pisa FE, Logroscino G, Casetta A, Cecotti L, Verriello L, Bratina A, Sartori A, Lazzarino de Lorenzo L, Eleopra R, Barbone R (2015) The Use of Antidepressant Medication before and after the Diagnosis of Amyotrophic Lateral Sclerosis: a population-based cohort study. Neuroepidemiology 44(2):91–98CrossRef PubMed
  37.Korner S, Kollewe K, Ilsemann J, Muller-Heine A, Dengler R, Krampfl K, Petri S (2013) Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis. Eur J Neurol 20(4):647–654CrossRef PubMed
  38.Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC (2009) Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73(15):1218–1226CrossRef PubMed PubMedCentral
  39.Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, Weber M (2012) EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)—revised report of an EFNS task force. Eur J Neurol 19(3):360–375CrossRef PubMed
  40.Abrahams S, Newton J, Niven E, Foley J, Bak TH (2014) Screening for cognition and behaviour changes in ALS. Amyotrophic Lateral Scler Frontotemporal Degen 15(1–2):9–14CrossRef
  
• 作者单位：Qianqian Wei (1)
  Zhenzhen Zheng (1)
  Xiaoyan Guo (1)
  Ruwei Ou (1)
  Xueping Chen (1)
  Rui Huang (1)
  Jing Yang (1)
  Huifang Shang (1)
  
  1. Department of Neurology, West China Hospital of Sichuan University, Chengdu, 610041, Sichuan, China
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Neurology
  Neuroradiology
  Neurosurgery
  Psychiatry
  
• 出版者：Springer Milan
• ISSN：1590-3478

文摘

To determine the prevalence of depression, to identify correlated factors for depression, and to explore the impact on the progression or survival of amyotrophic lateral sclerosis (ALS) by depression in a Chinese population. A total of 166 ALS patients were recruited. Diagnosis of depression disorders and the severity of depression were established by using the fourth diagnostic and statistical manual of mental disorders, Hamilton Depression Rating Scale-24 items (HDRS-24) and Beck Depression Inventory (BDI). Major depression was found in 15 patients (9.6 %). The multiple regression analysis showed that a lower ALS Functional Rating Scale-Revised (ALSFRS-R) score was correlated with increasing HDRS scores and BDI scores (P = 0.018 and P = 0.012). No significant difference in the median survival time between ALS patients with and without depression was revealed by Kaplan–Meier analysis (log-rank P = 0.282). Cox hazard model showed that the presence of depression in ALS was unrelated to the survival, while the severity of depression in ALS was correlated with the survival. The presence and severity of depression in ALS did not correlate with the progression of ALS. Major depression in ALS is uncommon. Depression evaluation should be given to ALS patients, especially those with lower ALSFRS-R score. The severity of depression may be associated with the survival; however, depression does not worse the progression of ALS.